A carregar...
Nephroprotection by SGLT2 Inhibition: Back to the Future?
The introduction of sodium/glucose cotransporter 2 inhibitors (SGLT2i) has opened new perspectives for the management of diabetic population at risk of or with chronic kidney disease (CKD). More important, recent, large real-world studies have repositioned the nephroprotective efficacy of SGLT2i eme...
Na minha lista:
| Publicado no: | J Clin Med |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7408701/ https://ncbi.nlm.nih.gov/pubmed/32679744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9072243 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|